TNP-470 (AGM-1470): mechanisms of action and early clinical development

Eur J Cancer. 1996 Dec;32A(14):2520-7. doi: 10.1016/s0959-8049(96)00388-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / pharmacology
  • Antibiotics, Antineoplastic / therapeutic use*
  • Cattle
  • Cells, Cultured
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Cyclohexanes
  • Drug Therapy, Combination
  • Endothelium, Vascular / drug effects
  • Humans
  • Macaca mulatta
  • Mice
  • Neoplasms / drug therapy*
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Physiologic / drug effects
  • O-(Chloroacetylcarbamoyl)fumagillol
  • Rats
  • Sesquiterpenes / adverse effects
  • Sesquiterpenes / pharmacology
  • Sesquiterpenes / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Cyclohexanes
  • Sesquiterpenes
  • O-(Chloroacetylcarbamoyl)fumagillol